Cargando…
Immunotherapy of Ovarian Cancer: The Role of Checkpoint Inhibitors
Ovarian cancer is the most important cause of gynecological cancer-related mortality, with the majority of women presenting with advanced disease. Although surgery and chemotherapy can improve survival rates, it is necessary to integrate alternative strategies to improve the outcomes. Advances in un...
Autores principales: | De Felice, Francesca, Marchetti, Claudia, Palaia, Innocenza, Musio, Daniela, Muzii, Ludovico, Tombolini, Vincenzo, Panici, Pierluigi Benedetti |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4508475/ https://www.ncbi.nlm.nih.gov/pubmed/26236750 http://dx.doi.org/10.1155/2015/191832 |
Ejemplares similares
-
Weekly versus three weeks chemotherapy for advanced ovarian cancer: a meta-analysis
por: Marchetti, Claudia, et al.
Publicado: (2016) -
Risk-reducing salpingo-oophorectomy: a meta-analysis on impact on ovarian cancer risk and all cause mortality in BRCA 1 and BRCA 2 mutation carriers
por: Marchetti, Claudia, et al.
Publicado: (2014) -
Efficacy and toxicity of bevacizumab in recurrent ovarian disease: an update meta-analysis on phase III trials
por: Marchetti, Claudia, et al.
Publicado: (2015) -
Fertility preservation in gynaecologic cancers
por: De Felice, Francesca, et al.
Publicado: (2018) -
Survival Nomograms after Curative Neoadjuvant Chemotherapy and Radical Surgery for Stage IB2-IIIB Cervical Cancer
por: Marchetti, Claudia, et al.
Publicado: (2018)